634 EVEREST-1: A seamless phase 1/2 study of CEA logic-gated Tmod CAR T-cell therapy (A2B530) in patients with solid tumors associated with CEA expression also exhibiting HLA loss of heterozygosity (LOH)
Salman R Punekar, Theodore Welling, J Randolph Hecht, Julian Molina, Caleb Smith, Edward Garon, M Pia Morelli, Marwan Fakih, Kedar Kirtane, Patrick M Grierson, Sandip P Patel, Yi Lin, Scott Kopetz, Frederick L Locke, Jeffrey Ward, Ariane Lozac’hmeur, Matthew Frigault, Sarah Nikiforow, Wen-Kai Weng, Jennifer Specht, Tomislav Dragovich, Judy Vong, Armen Mardiros, Kirstin Liechty, William Y Go, John Welch, Eric W Ng, Marcela Maus, David Maloney, Diane M Simeone
Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A724-A725; DOI: 10.1136/jitc-2023-SITC2023.0634
